GlaxoSmithKline Pharmaceuticals Quarterly Results for Trading Insights

GLAXO • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹258 Cr
QSept 2025
Quarterly Results

GlaxoSmithKline Pharmaceuticals Quarterly Results Key Highlights

  • Revenue of ₹1,016 Cr in Sept 2025 (+0.1% vs Mar 2025, -3.2% vs Sept 2024)
  • Net Profit of ₹258 Cr in Sept 2025 (-1.9% vs Mar 2025, +2.0% vs Sept 2024)
  • EBITDA of ₹372 Cr in Sept 2025 (-0.5% vs Mar 2025)
  • Operating Margin of 34.0% in Sept 2025 (+0.0pp vs Mar 2025)
  • Earnings Per Share of ₹15.07 in Sept 2025 (-2.9% vs Mar 2025)

GlaxoSmithKline Pharmaceuticals Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 1,016 1,015 849 1,091 1,050 0.1% -3.2%
Net Profit (₹ Cr) 258 263 205 296 253 - -
EBITDA (₹ Cr) 372 374 295 421 361 - -
EPS (₹) 15.07 15.52 12.10 16.54 14.67 - -
Operating Margin (%) 34.0% 34.0% 31.0% 36.0% 32.0% - -

GlaxoSmithKline Pharmaceuticals Share Price Trend Around Quarterly Results

Visualize GlaxoSmithKline Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for GlaxoSmithKline Pharmaceuticals

Additional stock information and data for GLAXO

GLAXO share price
GLAXO earnings multiple
GLAXO price range

Profitability Ratios

Profit Margin 25.4%
EBITDA Margin 36.6%
Operating Margin 34.0%
ROE (Annual) 52.9%

Balance Sheet Highlights

Total Assets ₹4,108 Cr
Total Equity ₹1,951 Cr
Current Assets ₹3,410 Cr
Current Liabilities ₹252 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,290 Cr
Investing Cash Flow ₹-46 Cr
Financing Cash Flow ₹-769 Cr
Net Cash Flow ₹475 Cr

Current Market Data

Current Price ₹2333.40
Exchange NSE
Last Updated Apr 07, 2026

Revenue Trend (₹ Cr)

Dec 2025 1,091
Jun 2025 849
Mar 2025 1,015
Sept 2025 1,016

Net Profit Trend (₹ Cr)

Dec 2025 296
Jun 2025 205
Mar 2025 263
Sept 2025 258

Operating Margin Trend (%)

Dec 2025 36.0%
Jun 2025 31.0%
Mar 2025 34.0%
Sept 2025 34.0%

Sector Competitors - Quarterly Performance Comparison

Comparing GlaxoSmithKline Pharmaceuticals quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1718.0 14,875 3,125 +10.8% - 21.0% 132.2
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5850.0 2,860 689 +7.1% - 24.1% 225.3
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4051.3 3,219 591 +11.3% - 18.4% 231.0
Lupin
Sept 2025 		₹102,578.78 Cr 2298.3 6,921 1,485 +23.2% - 21.5% 71.0
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1196.1 9,135 1,337 +1.1% - 14.6% 73.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores